Do psychedelics have therapeutic potential for obesity?
Nat Rev Endocrinol
.
2023 Jan;19(1):1-2.
doi: 10.1038/s41574-022-00769-1.
Authors
Nicole Fadahunsi
1
,
Gitte Moos Knudsen
2
3
,
Christoffer Clemmensen
4
Affiliations
1
Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark.
2
Neurobiology Research Unit, Department of Neurology, Copenhagen University Hospital, Rigshopitalet, Copenhagen, Denmark.
3
Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
4
Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark. chc@sund.ku.dk.
PMID:
36329153
DOI:
10.1038/s41574-022-00769-1
No abstract available
MeSH terms
Brain
Hallucinogens* / therapeutic use
Humans
Obesity / drug therapy
Substances
Hallucinogens